Healthcare provider profile · identity verified

Anne Michele Olson, MD

Family Practice · CAMBRIDGE, MN · NPI 1891758199

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	475	121
Amlodipine Besylate	Amlodipine Besylate	422	108
Metoprolol Succinate	Metoprolol Succinate	330	91
Atorvastatin Calcium	Atorvastatin Calcium	317	90
Losartan Potassium	Losartan Potassium	304	81
Omeprazole	Omeprazole	281	80
Simvastatin	Simvastatin	248	65
Lisinopril	Lisinopril	184	48
Gabapentin	Gabapentin	159	40
Famotidine	Famotidine	149	40
Hydrochlorothiazide	Hydrochlorothiazide	144	38
Glipizide Er	Glipizide	123	34
Rosuvastatin Calcium	Rosuvastatin Calcium	123	40
Atenolol	Atenolol	105	28
Metformin Hcl	Metformin Hcl	103	24
Fluoxetine Hcl	Fluoxetine Hcl	93	20
Paroxetine Hcl	Paroxetine Hcl	93	21
Eliquis	Apixaban	92	16
Metoprolol Tartrate	Metoprolol Tartrate	85	24
Sertraline Hcl	Sertraline Hcl	84	24
Spironolactone	Spironolactone	74	15
Tramadol Hcl	Tramadol Hcl	74	18
Ozempic	Semaglutide	68	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	67	18
Potassium Chloride	Potassium Chloride	63	18
Trazodone Hcl	Trazodone Hcl	62	19
Albuterol Sulfate Hfa	Albuterol Sulfate	57	31
Pravastatin Sodium	Pravastatin Sodium	57	15
Tizanidine Hcl	Tizanidine Hcl	57	23
Fluticasone Propionate	Fluticasone Propionate	56	24
Prednisone	Prednisone	56	31
Warfarin Sodium	Warfarin Sodium	55	15
Ibandronate Sodium	Ibandronate Sodium	54	18
Pantoprazole Sodium	Pantoprazole Sodium	54	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	13
Azithromycin	Azithromycin	51	31
Furosemide	Furosemide	48	20
Lovastatin	Lovastatin	45	13
Allopurinol	Allopurinol	44	13
Triamcinolone Acetonide	Triamcinolone Acetonide	44	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	19
Pioglitazone Hcl	Pioglitazone Hcl	43	13
Synthroid	Levothyroxine Sodium	43	11
Montelukast Sodium	Montelukast Sodium	42	13
Buspirone Hcl	Buspirone Hcl	41	17
Metformin Hcl Er	Metformin Hcl	41	16
Duloxetine Hcl	Duloxetine Hcl	40	suppressed
Estradiol	Estradiol	40	20
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Alprazolam	Alprazolam	35	11
Amoxicillin	Amoxicillin	33	18
Xarelto	Rivaroxaban	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Alendronate Sodium	Alendronate Sodium	31	suppressed
Cephalexin	Cephalexin	31	23
Terazosin Hcl	Terazosin Hcl	30	suppressed
Clonazepam	Clonazepam	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Lorazepam	Lorazepam	27	12
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	12
Valacyclovir	Valacyclovir Hcl	25	16
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	14
Trulicity	Dulaglutide	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Ketoconazole	Ketoconazole	21	14
Klor-Con M20	Potassium Chloride	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Hydrocortisone	Hydrocortisone	20	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Prazosin Hcl	Prazosin Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	15
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Diazepam	Diazepam	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Methylprednisolone	Methylprednisolone	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Sotalol	Sotalol Hcl	16	suppressed
Baclofen	Baclofen	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Carbamazepine Er	Carbamazepine	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	13	suppressed
Ramipril	Ramipril	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Primidone	Primidone	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error